HTX Launches “$1 Margin Trade”: Start Trading with Just 1 USDT, Enjoy Guaranteed First-Loss Coverage, Plus Share $40,000 in Rewards
PANAMA CITY, May 25, 2026 /PRNewswire/ -- For crypto beginners, the steep learning…
Marking its 20-year legacy, Star Health launches ‘Value Plus’ affordable health insurance with nearly 20% lower premiums
Star Health marks 20 years of its foundation with health insurance plan…
Davido, Alkaline & Wizkid to Headline Afro Plus Fest 2026
Festival Expands to Three Days at Northwest Stadium Complex in Prince George's…
GIGABYTE Launches Z890 Plus Series Motherboards Supporting Intel Core Ultra 200S Plus Series Processors and CQDIMM Technology
TAIPEI, March 11, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand,…
Artmarket.com publishes its 32nd Artprice Annual Report – The Art Market in 2025 – showing 12% growth, with the USA strengthening its dominant position. Plus Gemini Deep Think’s AI audit of Artprice’s strategy for 2026/2030
PARIS, March 10, 2026 /PRNewswire/ -- The 32nd Artprice Annual Report –…
Paingone Plus TENS Pen Featured in 2026 Consumer Report Examining FDA Clearance Status, TENS Pain Therapy Research, and Portable Pain Relief Device Verification
Tukwila, WA, March 05, 2026 (GLOBE NEWSWIRE) -- This report examines publicly…
Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema
October 28, 2025 16:05 ET | Source: Tactile Systems Technology, Inc. MINNEAPOLIS,…
DFSK Celebrates 20 Years of Global Expansion with E5 PLUS, the First Overseas New Energy Strategic Model, Rolls Off the Production Line
CHONGQING, China, Oct. 22, 2025 /PRNewswire/ -- On October 22, 2025, at…
IO Biotech Presents Phase 3 Results for Cylembio plus KEYTRUDA (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025
October 20, 2025 02:30 ET | Source: IO Biotech Cylembio plus pembrolizumab…
Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025
October 19, 2025 08:00 ET | Source: Replimune, Inc. WOBURN, Mass., Oct.…
